secwatch.observer — SEC 8-K summary
======================================

Issuer:     4D Molecular Therapeutics, Inc. (FDMT)
CIK:        0001650648
Form:       8-K
Filed at:   2023-11-22T23:59:59+00:00
Accession:  0001193125-23-282259
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

4D Molecular Therapeutics amends bylaws to update advance notice procedures
---------------------------------------------------------------------------

- Board amended and restated bylaws on November 16, 2023.
- Amendments update advance notice procedures for business brought before a meeting.
- Amendments update advance notice procedures for nominations of directors.
- Full text of Amended and Restated Bylaws filed as Exhibit 3.1 with the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650648/000119312523282259/0001193125-23-282259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650648/000119312523282259/d797882d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-282259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer